We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current SQZB market cap is 619.31k. The company's latest EPS is USD -2.6945 and P/E is -0.16.
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 12.67M | 20.11M | 21M | 27.1M | 21.48M |
| Operating Income | -20.4M | -34.27M | -51.06M | -68.77M | -80.68M |
| Net Income | -20.23M | -32.2M | -50.52M | -68.74M | -79.46M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 115.55M | 152.35M | 231.14M | 226.15M | 99.9M |
| Total Liabilities | 52.69M | 93.76M | 103.94M | 102.18M | 42.75M |
| Total Equity | -43.54M | -73.52M | 127.2M | 123.98M | 57.15M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 21.1M | -33.49M | -43.15M | -82.14M | -83.55M |
| Investing | -36.96M | -12.85M | 57.82M | -613k | -488k |
| Financing | 68.12M | 26.04M | 116.42M | 55.91M | 4.23M |
| Market Cap | 619.31k |
| Price to Earnings Ratio | -0.16 |
| Price to Sales Ratio | 0.59 |
| Price to Cash Ratio | 0.2 |
| Price to Book Ratio | 0.22 |
| Dividend Yield | - |
| Shares Outstanding | 29.49M |
| Average Volume (1 week) | 1.68k |
| Average Volume (1 Month) | 16.85k |
| 52 Week Change | -99.09% |
| 52 Week High | 2.90 |
| 52 Week Low | 0.0101 |
| Spread (Intraday) | 0 (0%) |
| Company Name | SQZ Biotechnologies Company (CE) |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://sqzbiotech.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
